Basit öğe kaydını göster

Salvage Use of Tigecycline for Severely Ill Children

dc.contributor.authorKara, Manolya
dc.contributor.authorTorun, Selda
dc.contributor.authorSomer, Ayper
dc.contributor.authorGurler, Nezahat
dc.contributor.authorAtay, Gurkan
dc.contributor.authorTÜREL, Özden
dc.contributor.authorSalman, Nuran
dc.contributor.authorAkturk, Hacer
dc.contributor.authorSutcu, Murat
dc.contributor.authorKarapinar, Bahar Akgun
dc.date.accessioned2021-03-06T08:04:20Z
dc.date.available2021-03-06T08:04:20Z
dc.date.issued2018
dc.identifier.citationKara M., Sutcu M., Akturk H., TÜREL Ö., Torun S., Karapinar B. A. , Atay G., Gurler N., Salman N., Somer A., "Salvage Use of Tigecycline for Severely Ill Children", JOURNAL OF PEDIATRIC INFECTION, cilt.12, ss.1-7, 2018
dc.identifier.otherav_df38ffcb-3610-476f-8e92-d64a4a8dc39d
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/147046
dc.identifier.urihttps://doi.org/10.5578/ced.67205
dc.description.abstractObjective: Tigecycline has a wide spectrum antimicrobial activity including multi-drug resistant and extended drug resistant nosocomial Gram-negative bacteria. Although its pediatric use has not been approved, clinicians are sometimes obligated to choose tigecycline as salvage therapy. In this study, we present our clinical experience regarding tigecycline use in children.
dc.language.isoeng
dc.subjectTıp
dc.subjectPEDİATRİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.titleSalvage Use of Tigecycline for Severely Ill Children
dc.typeMakale
dc.relation.journalJOURNAL OF PEDIATRIC INFECTION
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume12
dc.identifier.issue1
dc.identifier.startpage1
dc.identifier.endpage7
dc.contributor.firstauthorID251866


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster